Cerecor

Takeda Pharmaceuticals in Washington, DC is a global pharmaceutical company dedicated to creating better health for people and a brighter future for the world. Through advancing science and technology, Takeda aims to transform lives and improve health outcomes. With a focus on research and development in areas such as gastrointestinal and inflammation, rare diseases, oncology, neuroscience, and vaccines, Takeda is committed to innovative solutions for complex medical challenges. The company's mission is to move science forward to deliver sustainable, patient-centered growth and make a positive impact on global health. Generated from the website

Nutricia North America Company History Nutricia North America, a specialized medical nutrition company, is part of Medical Nutrition Division of Groupe Danone, Paris. Acknowledged as a market leader in infant and clinical nutrition, products range from infant formulas to specialized nutrition for babies with specific needs and for breastfeeding mothers. For people with specific nutritional requirements, Nutricia offers a complete range of enteral clinical and disease-specific nutritional products. Danone today controls interests in over 100 countries across the globe, delivering top quality baby food and clinical nutrition products including world renowned brands such as Cow & Gate, Milupa and Nutricia, including Neocate, Nutrilon and Omneo for babies and Nutrison, Fortimel, and Pre-Op for people requiring nutritional support. Nutricia has a world famous research facility supported by over 150 PhDs dedicated to developing innovative products that allow its Baby Food and Medical Nutrition divisions to deliver products for a better, healthier life. Nutricia Research co-operates with more than 50 university research centers across the globe. The results are seen in the quality and effectiveness of our products, and Nutricia's reputation continues to grow as an innovator in research and development, thereby meeting the demands of today's medical community and consumers. Nutricia North America, Inc ( formerly known as SHS North America ) was established in 1983 with offices in Rockville, MD. The Nutricia product line consists of a wide variety of FDA and Health Canada approved products used in the management of inherited metabolic diseases, severe allergic and gastrointestinal disorders as well as other conditions requiring nutritional therapy. Nutricia was the first to offer amino acid-based, hypoallergenic formulas ( the Neocate product line ) for the dietary management of cow milk protein allergy. The company has played a prominent role in educating the medical community through clinical trials and symposia on cow milk allergy and its associated enteropathies. Nutricia has over time diversified its product range by offering products specifically designed for intractable epilepsy' available under the brand name KetoCal' and innovative options for patients with phenylketonuria. Nutricia North America is rapidly transitioning from a relatively small affiliate of a European based nutrition company to a rapidly growing and strategically significant part of a global nutritional group.

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.